What should you know about a malaria mRNA vaccine?

An mRNA vaccine delivers temporary instructions that help cells make a harmless target protein. The immune system recognises that protein and prepares a response; the mRNA itself is then broken down. Malaria is caused by parasites with complex life stages, so vaccine design and protection are more complicated than the name alone suggests.

A vaccine discussion should be specific to the product, destination, age, pregnancy status, immune health, and travel timing. A vaccine is not a treatment for fever after travel and should not be used to explain away symptoms that require assessment.

Ask a travel clinician which malaria vaccines, if any, are authorised and recommended for your situation. Keep using repellent, covered clothing, and a mosquito net where advised. Ask whether malaria prophylaxis is also needed, because prevention plans may combine more than one measure. Keep a record of the product, doses, allergies, and any reaction after vaccination.

After vaccination, seek urgent help for trouble breathing, facial swelling, collapse, or rapidly worsening symptoms. During or after travel, seek prompt assessment for fever, chills, confusion, severe weakness, or repeated vomiting. Tell the clinician about recent travel and vaccination; a malaria illness needs a clinical assessment rather than assumptions about vaccine protection.

Which malaria vaccine applies to my destination and circumstances? What protection should I expect, and what other measures remain necessary? Could my medicines or health conditions affect vaccination or malaria prophylaxis?